Biochemical targets of drugs mitigating oxidative stress via redox-independent mechanisms

Area of Science:

• Biochemistry
• Pharmacology
• Pathophysiology

Background:

• Oxidative stress, caused by reactive oxygen and nitrogen species (RONS), is implicated in numerous diseases.
• Current treatments involve antioxidants or agents that boost endogenous antioxidant defenses.
• A third approach, using redox-inert compounds, offers a new avenue for managing oxidative stress.

Purpose of the Study:

• To review the third pharmacological approach for ameliorating oxidative stress using redox-inert compounds.
• To identify biochemical targets of drugs that mitigate acute oxidative stress in animal models.

Main Methods:

• Review of existing literature on pharmacological interventions for oxidative stress.
• Analysis of drug targets in animal models of ischemia-reperfusion injury and acetaminophen overdose.
• Identification of molecular pathways modulated by mitigating drugs.

Main Results:

• Redox-inert compounds can mitigate oxidative stress by inhibiting inflammation or aiding cellular coping mechanisms.
• Drug targets include pro-inflammatory molecules, protein kinases, transcription factors, and mitochondrial proteins.
• Other targets encompass endoplasmic reticulum stress pathways, nuclear receptors, and isoprenoid synthesis.

Conclusions:

• Pharmacological mitigation of oxidative stress via redox-inert compounds presents a promising therapeutic strategy.
• Understanding these drug targets may lead to the development of novel treatments for human diseases.
• This approach complements existing therapies for conditions associated with oxidative stress.